Related Experiment Video
Updated: Apr 19, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
[Beating heart cells--targeted diagnostics, individual optimization of therapy and tailored cell therapies]
Esko Kankuri1, Ari Harjula, Tommi Pätilä
1Helsingin yliopisto.
Insights
Heart damage from myocardial infarction is permanent due to the heart's limited repair capacity. Research into stem cells for cardiac repair shows low efficacy, but embryonic and iPS cells hold future promise.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Biology
Context:
- Myocardial infarction leads to irreversible heart scarring and functional decline.
- Current stem cell therapies for cardiac repair exhibit limited efficacy.
- Embryonic stem cells and induced pluripotent stem cells (iPS cells) are key research areas.
Purpose:
- To explore the potential of stem cells in repairing myocardial damage.
- To investigate the efficacy of various stem cell types in cardiac regeneration.
- To evaluate the future applications of stem cell-derived cardiomyocytes.
Summary:
- The heart's inability to self-repair after myocardial infarction necessitates therapeutic interventions.
- While adult stem cell treatments have shown low efficacy, embryonic stem cells and iPS cells present significant research opportunities.
- Stem cell-derived cardiomyocytes are crucial for advancing drug development, safety testing, and personalized medicine.
Impact:
- Advances in stem cell research could lead to novel treatments for heart disease.
- Improved cardiac repair strategies may restore heart function after infarction.
- The use of stem cell-derived cells promises to revolutionize pharmaceutical testing and patient-specific treatments.
Abstract:
Myocardial infarction causes scarring and loss of functional capacity of the heart, because the heart is itself unable to repair the damaged area. While the development of new forms of treatment for the repair of myocardial destruction has actually been investigated by introducing into the heart various stem cells present in an adult human, the efficacy of the treatments conducted in the studies has so far unfortunately been low. Embryonic stem cells and iPS cells are a highly significant research subject. Cardiomyocytes differentiated from stem cells are being studied also in drug testing, and they are expected to revolutionize drug development and safety tests of novel drugs as well as enable personalized medication in the future.
More Related Videos
08:19Author Spotlight: Shear Assay Protocol for the Determination of Single-Cell Material Properties
Published on: May 19, 2023
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Targeted Cancer Therapies
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...